Hospira Methotrexate Injection USP 50 mg/2 mL vial

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

sodium chloride, Quantity: 2.6 mg/mL; methotrexate, Quantity: 25 mg/mL

Boleh didapati daripada:

Hospira Australia Pty Ltd

INN (Nama Antarabangsa):

Methotrexate,sodium chloride

Borang farmaseutikal:

Injection

Komposisi:

Excipient Ingredients: benzyl alcohol; sodium hydroxide; water for injections; hydrochloric acid

Laluan pentadbiran:

Intraarterial, Intravenous, Intramuscular

Unit dalam pakej:

5 x 2 mL vials

Kelas:

Medicine Listed (Export Only)

Jenis preskripsi:

(S1) This Schedule is intentionally blank

Tanda-tanda terapeutik:

Methotrexate Injection USP belongs to a group of medicines known as anti-metabolites. It is used in high doses to treat certain types of cancers, including breast cancer, Non-Hodgkin's lymphoma and leukemia. At lower doses, it may also be used to treat severe psoriasis and severe rheumatoid arthritis.

Ringkasan produk:

Visual Identification: A yellow solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 30 Months; Container Temperature: Store between 15-25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status kebenaran:

Licence status A

Tarikh kebenaran:

2007-09-13